Aliment Pharmacol Ther 2022 Feb 27. doi: 10.1111/apt.16832. Online ahead of print.

Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study

Maria Pilar Ballester 1, Francisco Mesonero 2, Pablo Flórez-Diez 3, Concepción Gómez 1, Esteban Fuentes-Valenzuela 4, Noelia Martín 5, Carla Senosiain 2, Milagros Vela 6, Agnes Fernández-Clotet 7, Pablo Pérez 8, Cristina Rubín de Célix 9, Cristina Calviño-Suárez 10, Benito Hermida 11, Roser Muñoz 12, Maria González-Vivo 13, Eduard Brunet 14, Nuria Jiménez 15, Belén Botella 16, Jorge Yebra 17, Cristina Suárez-Ferrer 18, Abdel Bouhmidi 19, Antonio López-Serrano 20, Ángel Ponferrada 21, Carmen Dueñas 22, Miguel Mínguez 1, Young Group of AEG and GETECCU

Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey

[Article in English, Spanish]

Alfonso Elosua González 1, Óscar Nantes Castillejo 2, Ignacio Fernández-Urién Sainz 3, Alicia López-García 4, Óscar Murcia Pomares 5, Yamile Zabana 6, en nombre de Grupo Joven GETECCU y del Grupo Joven de AEG

Affiliations expand

PMID: 33872625 DOI: 10.1016/j.gastrohep.2021.02.013

Abstract

Introduction: Small bowel capsule endoscopy (SBCE) is a non-invasive diagnostic technique whose use in inflammatory bowel disease (IBD) has spread. A panenteric capsule, PillCam Crohn's (PCC), has recently been developed. We lack information on the availability and use of the CEID and PCC in our environment.

Methods: We conducted an electronic and anonymous survey among the members of the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) [Spanish Working Group on Crohn's Disease and Ulcerative Colitis] and the Asociación Española de Gastroenterología (AEG) [Spanish Association of Gastroenterology], consisting of 37 multiple-choice questions.

Results: One hundred and fifty members participated, the majority dedicated to IBD (69.3%). 72.8% worked at centres with an IBD unit. 79% had SBCE available at their hospital, 14% referred patients to another centre; 22% had a PCC available, 9% referred patients to another centre. 79.3% of respondents with available SBCE used it in a small percentage of patients with IBD and 15.6% in the majority. The most frequent scenarios were suspicion of Crohn's disease (76.3%), assessment of inflammatory activity (54.7%) and assessment of the extent of the disease (54.7%). More than half (59.7%) preferentially used the Patency capsule to assess intestinal patency. Almost all respondents (99.3%) considered that training resources should be implemented in this technique.

Conclusions: SBCE is widely available in Spanish hospitals for the management of IBD, although its use is still limited. There is an opportunity to increase training in this technique, and consequently its use.

Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?

Del Hoyo J, Millán M, Garrido-Marín A, Nos P, Barreiro-de Acosta M, Bujanda L, de la Portilla F, Aguas M; AEG, AECP, GETECCU.

Gastroenterol Hepatol. 2021 Sep 8:S0210-5705(21)00249-1. doi: 10.1016/j.gastrohep.2021.08.006. Online ahead of print.

PMID: 34508808 

Enlace desde la web AEG, GETECCU. Documento en abierto:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425749/

Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG

[Article in English, Spanish]

Javier Crespo 1, Raúl Andrade 2, Fernando Alberca de Las Parras 3, Francesc Balaguer 4, Manuel Barreiro-de Acosta 5, Luís Bujanda 6, Ana Gutiérrez 7, Francisco Jorquera 8, Julio Iglesias-García 9, Andrés Sánchez-Yagüe 10, José Luis Calleja 11

Affiliations expand

PMID: 32409107 PMCID: PMC7183290 DOI: 10.1016/j.gastrohep.2020.04.001

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

Ivan Guerra, Luis Bujanda, Jesús Castro, Olga Merino, Joan Tosca et al.

PMID: 31063540 DOI: 10.1093/ecco-jcc/jjz094

METHODS: PSC-IBD patients were identified from the Spanish ENEIDA registry of GETECCU. Additional data were collected using the AEG-REDCap electronic data capture tool.